Press release
Erythropoietin Drugs Market 2023: progressive trends, growth opportunities and revenue forecast to 2030
Key Takeaways:
The kidney disorder segment is expected to manifest the highest CAGR of 6.5% during the forecast period.
The market across Asia-Pacific is projected to register the highest CAGR of 7.8% from 2021 to 2028.
The epoetin-alfa segment is estimated to register the highest CAGR of 7.0% during the forecast period.
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/59
Major Factors Driving the Growth of Erythropoietin Drugs Market:
Rising prevalence of anemia: Anemia is a condition characterized by a lack of red blood cells, which can lead to fatigue, weakness, and difficulty breathing. The prevalence of anemia is rising globally due to a number of factors, including chronic diseases such as cancer and kidney disease, malnutrition, and infections. EPO drugs are used to treat anemia by stimulating the production of red blood cells.
Expanding range of applications: EPO drugs are now being used to treat a wider range of conditions than ever before. In addition to anemia, EPO drugs are also used to treat chronic kidney disease, cancer, and other conditions that can lead to low red blood cell counts.
Technological advancements: Technological advancements have led to the development of new and more effective EPO drugs. For example, second- and third-generation EPO drugs have longer half-lives and are more effective at stimulating the production of red blood cells than first-generation EPO drugs.
Increasing awareness of EPO drugs: Awareness of EPO drugs is growing among patients and healthcare professionals. This is due to public awareness campaigns and educational initiatives. This is driving the demand for EPO drugs.
Market Segmentation:
By drug type:
First-generation EPO drugs (e.g., epoetin alfa and epoetin beta)
Second-generation EPO drugs (e.g., darbepoetin alfa)
Third-generation EPO drugs (e.g., methoxy polyethylene glycol-epoetin beta)
Biosimilars
By application:
Anemia
Chronic kidney disease
Cancer
Other applications (e.g., heart failure and peripheral artery disease)
By end user:
Hospitals
Clinics
Home healthcare settings
By region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Request for Customization: https://www.alliedmarketresearch.com/request-for-customization/59
Regional Growth Dynamics:
North America dominates the global erythropoietin drugs market, owing to presence of several approved and commercialized erythropoietin biosimilars. However, Asia-Pacific is characterized by presence of generic epoetin products. Asia-Pacific and LAMEA offer promising growth opportunities for erythropoietin manufacturers as these regions are less explored for erythropoietin drugs as compared to North America and Europe.
Competitive Landscape:
Johnson & Johnson
Amgen Inc.
Roche
Hospira Inc.
Biocon
LG Life Sciences Ltd.
Teva Pharmaceutical Industries Ltd.
Intas Pharmaceuticals
Ranbaxy Laboratories Ltd.,
Celltrion, Inc.
Key Questions Answered in the Intelligent Study
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Buy this Premium Research Report:
https://www.alliedmarketresearch.com/purchase-enquiry/59
Why Choose Allied Market Research?
Industries' Best Analysts
Exclusive Product Offerings
Customer Research Services
Dynamics Research Methodology
Comprehensive Reports
Latest Technological Advancements
Value Chain Analysis
Future Market Opportunities
Market Growth Dynamics
Quality Assurance
Post-sales Support
Continuous Report Update
Market Dynamics and Transformations
Economic Downturn Analysis: Impact of Recession in 2023
Pandemic's Influence: Impact of Covid-19 Pandemic
Market Evolution: Recent Developments in the Market with Key Players
Browse more latest healthcare reports:
Defibrillator Market: https://www.alliedmarketresearch.com/defibrillator-market
Cancer Biomarkers Market: https://www.alliedmarketresearch.com/cancer-biomarkers-market
Preimplantation Genetics Diagnosis Market: https://www.alliedmarketresearch.com/preimplantation-genetic-diagnosis-market
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erythropoietin Drugs Market 2023: progressive trends, growth opportunities and revenue forecast to 2030 here
News-ID: 3309133 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for EPO
Erythropoietin (EPO) Treatment Market Outlook and Future Projections for 2030
The erythropoietin (epo) treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the…
Erythropoietin (EPO) Treatment Market, Global Outlook and Forecast 2025-2033
Summary: The Global Erythropoietin (EPO) Treatment Market was valued at US$9242 million in 2022 and is projected to reach US$ 19070 million by 2033, at a CAGR of 6.2% during the forecast period. The Global Erythropoietin (EPO) Treatment Market was valued at US$ 9.24 billion in 2022 and is expected to reach US$ 14.07 billion by 2029, growing at a 6.2% CAGR. EPO is primarily used to treat anemia caused…
Erythropoietin (EPO) Market Analysis & Growth Insights 2024-2033
The Business Research Company recently released a comprehensive report on the Global Erythropoietin (EPO) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
EPO Biomarkers Market Size, Share | Forecast 2032
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global EPO Biomarkers Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in…
Erythropoietin (EPO) Drugs Market: An Overview
Introduction:
Erythropoietin (EPO) is a glycoprotein hormone that plays a crucial role in regulating red blood cell production (erythropoiesis) in the body. EPO drugs are synthetic versions of this hormone used to treat anemia, particularly in patients with chronic kidney disease (CKD), cancer, HIV, and other critical conditions that impact red blood cell production. EPO drugs help maintain adequate hemoglobin levels, improving the quality of life for patients by reducing the…
Global EPO Biomarkers Market Research and Forecast 2018-2023
Global EPO biomarkers market size, market intelligence, market trends, research and analysis report by biomarker (erythropoietin alfa, beta, zeta, theta, recombinant human erythropoietin, darbepoetin alfa) by applications (end-stage renal disorder, cancers, rheumatoid arthritis, aids, myelodysplastic syndrome, neurology, hematology) forecast 2018-2023
According to the OMR analysis, the global EPO biomarkers Market is expected to grow impressively during 2018-2023. The global EPO biomarkers market is segmented on the basis of biomarker type, applications,…
